Uncovering the role of non-classical islet peptides in the function of the pancreatic islets and regulation of beta cell function.

Therapeutic utility of novel stable forms of the naturally-occurring gut peptide xenin and their potential to restore the biological action of GIP in type 2 diabetes.

Synthesis, Evaluation and Optimisation of a Novel drug Delivery System.

Creating a structural diversity library of DNA Quadruplexes that inhibit cancer cell growth.

An investigation of the potential biocidal activity of microbial biosurfactants against bacteria important in oral and personal hygiene.

Vitamin B12 requirements through the lifecycle.

New approaches to investigate novel gene nutrient interactions in hypertension.

Understanding the relationship between psychological wellbeing and food choice.

Vitamin D and athletes.

An investigation of the relationship between exposure to inorganic and organic mercury and disease activity in systematic lupus erythematosus?

Control of biofilm production in pathogenic Pseudomonas aeruginosa strains.

The role of Nrf-2 in the anti-gentoxic effects of berry metabolites.

Cross Talk between the Vitamin D and NF-kB Signalling Pathways Link Drug Metabolism and Inflammation.

Investigating the mechanisms behind human imprinting disorders using model systems.

Pre-clinical evaluation of Oct-1002 to control prostate cancer malignant progression.

Development of personalised gene-silencing treatment for keratin disorders.

Beta-amyloid accumulation and cataracts in the Down Syndrome eye.

The NICER study: effects of environment and diet on refractive outcome.

Towards individualizing chemotherapy combination treatments in myeloma.

Sophorolipid-mediated inhibition of tumour growth.

The role of glycosylated acute phase response proteins on SIGLEC1 regulation of circulating macrophages in Rheumatoid Arthritus.

Investigations of the neuroprotective effects of novel Oxyntomodulin analogues in animal models of Alzheimer and Parkinson’s disease.

Sonosensitiser loaded microbubbles as targeting drug conjugates in the treatment of cancer.

Transfer of antibiotic resistances between human pathogenic bacteria in natural biofilms.

Evaluation of novel glucagon-oxyntomodulin-incretin hybrid peptide for diabetes and obesity therapy.

Development of an educational resource to assist the dietary compliance of older adults (>65 years) with type 2 diabetes.

Uncovering the mechanism of action and enhancing the beneficial effects of prolonged cholecystokinin receptor signalling in obesity.

Assessing the potential of novel dual agonist peptide analogues for diabetes therapy.

Physiological and biochemical characterisation of C.difficile mutants.

Peptidomic analysis and biological characterisation of novel amphibian skin peptides and naturally occurring bioactive compounds for the treatment of type-2 diabetes.

Isolation and characterization of phytochemicals with insulin-releasing or glucose lowering effects for the treatment of type-2 diabetes.

The effect of soy isoflavones on cognitive function and menopausal symptoms in early postmenopausal women.

Design and development of particulate carrier systems for delivery and targeting of biotherapeutics.

Assessing the potential link between metformin usage and vitamin B12 depletion in Type 2 diabetic subjects.

Development of molecular methods to study the eukaryotic gut microflora of healthy individuals.

The role of lactobacilli in reducing the infectious disease capacity of antibiotic resistant salmonella.

Multiplex detection of Clostridium difficile using luminescent nanoparticles targeted to pathogen biomarkers.